FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CSK |
CSK: Tyrosine-protein kinase CSK |
3.157 |
Evidence |
|
SEC24C |
SEC24C, KIAA0079: Protein transport protein Sec24C |
FLII |
FLII, FLIL: Protein flightless-1 homolog |
3.157 |
Evidence |
|
GABRB1 |
GABRB1: Gamma-aminobutyric acid receptor subunit beta-1 precursor |
GLRB |
GLRB: Glycine receptor subunit beta precursor |
3.157 |
Evidence |
|
EIF3S8 |
EIF3S8: Eukaryotic translation initiation factor 3 subunit 8 |
COPS3 |
COPS3, CSN3: COP9 signalosome complex subunit 3 |
3.157 |
Evidence |
|
TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
3.157 |
Evidence |
O
|
CSK |
CSK: Tyrosine-protein kinase CSK |
JAK1 |
|
3.157 |
Evidence |
|
COPS3 |
COPS3, CSN3: COP9 signalosome complex subunit 3 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
3.157 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
JUND |
JUND: Transcription factor jun-D |
3.157 |
Evidence |
O
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
JAK1 |
|
3.157 |
Evidence |
|
SMARCC2 |
SMARCC2, BAF170: SWI/SNF-related matrix-associated actin-dependent regulator of |
FOXA2 |
FOXA2, HNF3B, TCF3B: Hepatocyte nuclear factor 3-beta |
3.152 |
Evidence |
|
DTNA |
DTNA, DRP3: Dystrobrevin alpha |
ACTN1 |
ACTN1: Alpha-actinin-1 |
3.152 |
Evidence |
|
ACTN4 |
ACTN4: Alpha-actinin-4 |
DTNA |
DTNA, DRP3: Dystrobrevin alpha |
3.152 |
Evidence |
|
UTRN |
UTRN, DMDL: Utrophin |
DTNA |
DTNA, DRP3: Dystrobrevin alpha |
3.152 |
Evidence |
|
FOXA1 |
FOXA1, HNF3A, TCF3A: Hepatocyte nuclear factor 3-alpha |
SMARCC2 |
SMARCC2, BAF170: SWI/SNF-related matrix-associated actin-dependent regulator of |
3.152 |
Evidence |
|
GYS1 |
GYS1, GYS: Glycogen [starch] synthase, muscle |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
3.15 |
Evidence |
|
SRPK1 |
SRPK1: Serine/threonine-protein kinase SRPK1 |
HSP90AA1 |
Hsp89-alpha-delta-N |
3.15 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
3.15 |
Evidence |
|
PSKH1 |
PSKH1: Serine/threonine-protein kinase H1 |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
3.145 |
Evidence |
|
STXBP3 |
STXBP3: Syntaxin-binding protein 3 |
STX1B2 |
STX1B, STX1B1, STX1B2: Syntaxin-1B |
3.142 |
Evidence |
|
NME2P1 |
NME2P1: Putative nucleoside diphosphate kinase |
NME2 |
NME2, NM23B: Nucleoside diphosphate kinase B |
3.142 |
Evidence |
|
AKR1A1 |
AKR1A1, ALDR1, ALR: Alcohol dehydrogenase [NADP+] |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
3.142 |
Evidence |
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
3.142 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
3.142 |
Evidence |
|
COPB2 |
COPB2: Coatomer subunit beta' |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
3.142 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
3.142 |
Evidence |
|